• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Republican congressman will end monthslong absence from DC after missing 135 roll call votes

by June 19, 2026
written by June 19, 2026

After more than 100 days away from Capitol Hill, Rep. Tom Kean Jr., R-N.J., is set to return to Washington, D.C., in the coming weeks.

Kean, 57, will be present for votes during the June 30 session, a spokesperson for the congressman confirmed to Fox News Digital. The two-term New Jersey lawmaker has been sidelined for months with a personal health issue and has yet to disclose the nature of the ailment. 

Kean has pledged to be transparent about his illness once he is back in Washington.

The New Jersey Globe first reported the timing of Kean’s expected return. He previously told the outlet his medical issue did not affect his cognitive health and will not have any chronic complications that could impair his ability to seek a third House term.

HOUSE REPUBLICAN MISSES ANOTHER WEEK OF VOTES AS HEALTH ABSENCE STRAINS THIN MAJORITY

The embattled lawmaker has not been seen in public or cast a vote on the House floor since early March, amounting to 135 missed roll call votes, according to GovTrack.

Kean’s office has still continued to introduce legislation and post on social media. 

The New Jersey Republican’s expected return to Washington ahead of November’s midterm elections will be relatively short-lived. With just over 30 legislative days remaining, lawmakers are scheduled to spend nearly all of August and October back home campaigning for re-election. 

DEMS PICK CHALLENGER FOR GOP CONGRESSMAN WHO VANISHED FROM PUBLIC VIEW AMID HEALTH MYSTERY

Thursday’s announcement comes as Kean is facing a significant reelection challenge from former Navy helicopter pilot Rebecca Bennett in one of the country’s most competitive House battleground districts.

Bennett, who is expected to lean into her national security background on the campaign trail, defeated several Democrat primary challengers in May to advance to the general election.

She has largely refrained from criticizing Kean during his absence but said he must be transparent with voters about his health issue.

Kean, who has the endorsement of President Donald Trump, ran unopposed for the GOP nomination, but his future in Congress remains unclear amid his absence and health concerns. 

The nonpartisan Cook Political Report rates the New Jersey contest in the suburban swing seat as a “toss-up.”

<!–>

–>

0 comment
0
FacebookTwitterPinterestEmail

previous post
Cathie Wood buys more Tesla, cuts Roku as ARK doubles down on AI
next post
Walz approval rating craters to lowest level ever and trails Trump amid massive fraud scandal: ‘Tired of it’

related articles

Cruz says winning AI race against China is...

September 26, 2026

US, China strike deal to lower tariffs on...

September 26, 2026

Dem House hopeful endorsed by activist who said...

September 26, 2026

Trump claims stunning casualty numbers in Russia-Ukraine war

September 26, 2026

Unearthed: El-Sayed called for repealing law that made...

September 25, 2026

Trump to usher in ‘golden age’ of American...

September 25, 2026

Xi’s 100K invitation to America’s youth sets off...

September 25, 2026

Trump scores Supreme Court win in election integrity...

September 25, 2026

‘Squad’ Democrat slammed by Trump admin for most...

September 25, 2026

GOP handed new lifeline on biggest pocketbook fight...

September 25, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Asia tech rallied again but Korea’s fade may be the signal Japan should watch

    September 22, 2026
  • Rocket Lab stock analysis: megaphone forms as experts remain optimistic

    July 6, 2026
  • FIRST ON FOX: DHS points to ‘common sense’ reason for collapsing crime: ‘No surprise’

    August 1, 2026
  • Intuit stock is the worst performer in the Nasdaq 100 Index this year: buy the dip?

    June 9, 2026
  • DAX, CAC 40, IBEX, and Stoxx 50 in focus ahead of the ECB interest rate decision

    June 11, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (671)
  • Investing (1,509)
  • Stock (90)

Latest Posts

  • Is Oracle stock a buy after its 14% decline in the last five sessions?

    September 16, 2026
  • BlackBerry shares rally on higher Q1 profit and improved revenue forecast

    June 26, 2026
  • Why is Oracle stock gaining 4% today?

    September 17, 2026

Recent Posts

  • Keir Starmer resigns as British prime minister after devastating Labour revolt and local election losses

    June 22, 2026
  • Senate map tightens as top forecaster moves 3 races toward Democrats

    June 11, 2026
  • Buy GE Vernova, Lam Research, United Airlines stocks: Morgan Stanley

    July 15, 2026

Editor’s Pick

  • Evening digest: Broadcom extends Apple deal, Strategy sells $216M worth of Bitcoin

    July 6, 2026
  • Capitol sex scandals spark push to ban House lawmakers from sleeping with staffers

    July 30, 2026
  • Vodafone shares jump as UAE firm exits with $5.9B stake sale to Xavier Niel

    July 10, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock